FreeCME

Refining the Maintenance Protocol for Advanced Ovarian Cancer

CME: 1.0

The recent availability of PARP inhibitors as maintenance therapy in the first-line setting allows clinicians to offer improved treatment options to their patients with ovarian cancer.

Post a comment to this article